Amedisys Inc is a healthcare company that provides home health care services, hospice care, and long-term acute care hospital services across the United States
Focused on delivering high-quality, patient-centered care, the company aims to support patients in managing their health conditions in the comfort of their homes. Amedisys utilizes a dedicated team of healthcare professionals, including nurses and therapists, who collaborate to create personalized care plans tailored to the specific needs of each patient, thereby enhancing their quality of life and promoting recovery.
President Trump has spoken about implementing a family caregiver tax credit during his presidential campaign to ease the burden on caregivers, here's who gains.
UnitedHealth shares a quarterly report for the first time since the death of insurance unit leader Brian Thompson. A look at the estimates and key items to watch.
UnitedHealth shares have declined 5.3% over the past week. The company faces a significant legal challenge to its $3.3 billion acquisition of Amedisys.
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to VitalCaring, aims to balance growth and competition.
UnitedHealth Group Inc (NYSEUNH) shares are trading lower Tuesday. The U.S. Justice Department is moving to block the company's multi-billion acquisition of Amedisys Inc NASDAQ:AMEDNASDAQAMED)
BALA CYNWYD, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
BALA CYNWYD, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
BALA CYNWYD, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
BALA CYNWYD, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
BALA CYNWYD, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Amedisys, Inc. (“Amedisys” or the “Company”) (Nasdaq – AMED) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Optum (“Optum”). Under the terms of the Agreement, Amedisys shareholders will only $101.00 per share in cash.
